Abstract. The merozoite surface protein-1 (MSP-1) of Plasmodium vivax exhibits great antigenic diversity among different isolates of this parasite. This antigen is a useful genetic marker for studying the polymorphism of natural P. vivax parasite populations. One or more of these populations has been responsible for resurgent malaria now occurring in Korea. This paper reports the analysis of a highly polymorphic region between interspecies conserved blocks 5 and 6 of the MSP-1 gene, using the polymerase chain reaction to amplify the DNA fragment encompassing these regions from 25 Korean isolates, followed by sequencing. Almost all amino acid sequences of Korean isolates were nearly identical to that of Thai isolates TD525A (96.6-99.7%) and TD424 (96.3-99.5%), and very similar to that of the France-Belem strain when compared with other isolates (Sal-1, Sri Lanka, and Colombia). Interallelic recombination was found in the poly-Q repeat and a Sal-1 type amino acid structure was observed in all isolates. This study shows that the MSP gene nucleotide sequence of resurgent P. vivax in Korea is most similar to that of Thai isolates; however, the Korean strains are phylogenetically unique.
Korea has classically been an area of endemic tertian malaria. In ancient Korea, the medical term for this disease was HakJil. HakJil (common names ϭ Haruguli or Jegusil) described the nature of the disease, which showed a periodic fever at 24-hr intervals. It also described the socially popular recognition of the disease, in which it is acknowledged that adults have recovered from malaria. In 1913, Hasegawa reported the presence of malaria in Korea. In 1926, Himeno described the clinical characteristics of the Korean type of malaria. According to his report, malaria in Korea was caused by Plasmodium vivax. 1 In 1952, during the Korean War, Hale and Halpenny reported P. vivax malaria in Korea among U.S. Army troops. (6.6% had malaria symptoms). 2 In the 1960s, the Korea National Malaria Eradication Service, supported by the World Health Organization and the Government of the Republic of Korea, studied the prevalence of P. vivax malaria in Korea. For malaria project surveys, passive case detection proved to be the only practical mechanism to obtain reliable data required for the delimitation of malarious areas. A malaria map of the country was completed at the end of 1965. An intensive control program began with a coordinated program of case detection and vector control. 3 Effective eradication efforts tailored towards specific malaria risk areas resulted in South Korea becoming free of malaria after 1979. In 1993, a few malaria patients were diagnosed who had never been to foreign countries, but who had served in the South Korean Army in the Demilitarized Zone (DMZ) (buffer between the People's Democratic Republic of Korea [North Korea] and the Republic of Korea (South Korea) in northern Kyunggi province. 4 After 1993, malaria expanded exponentially each year, with more than 2,100 patients diagnosed up to 1997. Current epidemiologic surveys suggest that the resurgent malaria did not originate from overseas. Our data reveal that a resurgent strain can have a long incubation period (from 230 to 300 days), with characteristics very similar to a North Korean strain described by Shute and others. 5 Merozoite surface protein-1 (MSP-1) is an antigen found on the merozoite form of the malaria parasite, and is the current focus of vaccine development against asexual blood stages. [6] [7] [8] There is evidence that MSP-1 can elicit protective immune responses against asexual blood stage challenge in animal models. 7, 8 The MSP-1 gene consists of 10 units, including conserved, semi-conserved, and polymorphic segments. The gene coding for MSP-1 of P. vivax (Pv200) has been characterized in 2 isolated strains: Brazilian-Belem and Salvador-1. 7, 8 A study of field isolates from Sri Lanka showed that the P. vivax MSP-1 genes of the Belem and Salvador-1 strains underwent intragenic recombination in polymorphic regions while in mosquito vectors. 9, 10 Analysis of MSP-1 polymorphism has served to enhance the findings of epidemiologic and molecular biological surveys on the origins of the Korean strains of P. vivax. Since there is no data on the MSP-1 gene of the North Korean strain, it is not known whether the re-emergence of P. vivax malaria originated from North Korea. Circumsporozoite protein and Duffy blood-like genes would be another key in solving the mystery of the origin of re-emergent malaria in Korea.
We studied MSP-1 by gene amplification using the polymerase chain reaction, mapping polymorphic regions between interspecies conserved blocks 5 and 6, and analyzing the polymorphic sequence of Korean isolates compared with other similar P. vivax strains. However, it was not possible to compare direct nucleotide sequences to any previous or current North Korean strains.
SUBJECTS, MATERIALS, AND METHODS
Subjects and sample collection. Blood samples were collected from 25 patients diagnosed with P. vivax by microscopy in 1996 (n ϭ 12) and 1997 (n ϭ 13) from the Pajoo and Yonchon areas of Korea. Informed consent was obtained from all patients before collection of blood samples. The study was reviewed and approved by the Malaria Research Group of the Institute of Emerging Infectious Diseases of Korea University. Clinical characteristics of samples are summarized in Table 1 . After identification either whole blood samples were frozen at Ϫ80ЊC or blood was first separated into packed cells and plasma and then frozen at → FIGURE 2. Phylogenetic tree generated by the unweighted pair-group method of assortment using Phylogenetic Analysis Using Parsimony (version 4.0b) based on the 127 amino acid region of the merozoite surface protein-1 gene of Plasmodium vivax isolates from Korea and those of worldwide strains. Korean isolates formed one group and are more closely related to the France-Belem type than to the Sal-1 type. The length of the line (bottom left) is proportional to the genetic differences (%).
Ϫ80ЊC. Parasite DNA was extracted from whole blood and packed cells using a commercial matrix (InstaGene; Bio-Rad Laboratories, Hercules, CA) kit.
Polymerase chain reaction amplification of the MSP-1 gene. Sequences were amplified by the PCR using the following oligonucleotide primers that allowed amplification of a nucleotide region of the polymorphic region of the MSP-1 gene corresponding to basepairs 1984-2653 (Belem strain interspecies conserved blocks 5-6 region); MSP-1A (5Ј-GAGCCCTACTACTTGATGGTCC-3Ј) and MSP-1B (5Ј-
. Amplified products were fractionated by electrophoresis on 1.5% agarose gels containing ethidium bromide (0.5 mg/ml). The PCR products were purified using the Wizard PCR Preps DNA Purification System (Promega, Madison, WI). Sequencing of DNA was performed in both directions of each PCR product using the Dye Termination Cycle Sequencing Ready Reaction Kit (Applied Biosystems Inc., Foster City, CA) on an automated sequencer (Model 377, Perkin-Elmer).
Phylogenetic analysis. Gene sequences of parasites from blood samples of 23 malaria patients were aligned and compared with previously published MSP-1 gene sequences. The Genbank accession numbers for MSP-1 gene sequences in Korea were AF098279, AF098280, AF098281, AF098282, and from AF153016 to AF153032. Alignment and comparison of the 122 amino acid sequence (366-nucleotide region of the MSP-1 gene) were facilitated by using various programs of Lagergene (DNASTAR, Madison, WI). For phylogenetic analysis, the unweighted pair-group method of assortment (Phylogenetic Analysis Using Parsimony, version 4.0.b; Sinauer Associates, Inc., Sunderland, MA) was used.
RESULTS
The MSP-1 gene was amplified from total parasite genomic DNA obtained from 25 patients. A 669-basepair DNA fragment that included the poly-Q repeat was amplified from all of these samples. Sequencing results were obtained from 24 cases. A 383-basepair fragment was sequenced and shown to contain 127 amino acids. The 24 Korean isolates showed high similarity in their amino acid sequences (91.1-100%). Compared with other strains, the most similar strains were the Thai isolates TD525 (96.6-99.7%) and TD424 (96.3-99.5%). The next most similar isolates are 2 from Brazil (Patient 9, 94.3-96.2% and Patient 10, 93.5-96.3%). Variable numbers of poly-Q repeat regions, glutamine residues, were found in 4-10 repeats in Korean isolates (Figure 1) . However, 10 repeats of poly-Q were most common type (n ϭ 21) and others showed 6 (n ϭ 1), 5 (n ϭ 1), and 4 (n ϭ 1) repeats. The type 2 amino acid sequence of the Sal-1 strain (NKPTVAAADIVAKGQSLRGASETGTTGNTVNA-QTAVVQ) was also found before the poly-Q repeat region in all Korean isolates (n ϭ 24) (Figure 1 ). There were no distinct phylogenetic differences between the isolates from different areas in South Korea (Pajoo, Yonchon, Chorwon, or Kimpo). Phylogenetic analysis showed that Korean isolates can form one group, but were separated from isolates of other regions by various distances (Figure 2 ).
DISCUSSION
Indigenous malaria was eradicated in South Korea in late 1970s. The only reports of malaria in this country have been in travelers to other countries. Recently, malaria has reemerged in South Korea, especially in the DMZ north of the Imjin River. After the sentinel cases in 1993, the number of reported malaria cases has grown exponentially. In 1997, more than 1,600 cases were reported in South Korea. 11 Within the United States Forces in Korea (USFK), there has also been 27 cases diagnosed with P. vivax malaria. These USFK personnel come from the United States and stay in Korea for usually 1 year. To date, no USFK personnel have been infected with P. vivax outside Korea; the cases have had the same history, bitten by mosquitoes at night in the DMZ between June and September. Almost 30-40% become ill 9 months later, when back in the United States. The others become ill in Korea, either within a month of being infected or between May and July of the following year. An epidemiologic survey suggested that the malaria was caused by a Korean strain, and not a strain from overseas (e.g., China 11 ). Several points support this suggestion. First, there appears to be a point source for the sentinel cases. Most cases were infected along the DMZ adjacent to North Korea. Due to the isolation of this country, almost nothing is known about the status of malaria transmission north of the DMZ. Second, the incubation period of resurgent P. vivax malaria in Korea is unusual. Our data showed that the resurgent strain has a long incubation period (9-33 months) after exposure in risky areas (Table 1) . Third, the yearly rate of malaria cases has increased almost 4-fold each year from 1994 to 1997. This is similar to the findings of Shute and others with the North Korean strain of P. vivax. 5 In 1996, we studied antigen and antibody rates of residents in the endemic area of Dae-Sung Dong (Institute for Environmental Health, Kyunggi Province Korea, 1997, unpublished data). Among 77 healthy residents, 4 (5.2%) were positive for antibodies to malaria by an indirect immunofluorescence test. Two cases showed gametocytes in peripheral blood smears stained with Giemsa. In 1998, we also collected donated blood from Army personnel in the Pajoo area from the Korea Red Cross Blood Center. Results of a recombinant anti-MSP ELISA showed that the rate of malaria antibody positivity was 8% (Lim CS and others, unpublished data). The situation in North Korea is similar to that in South Korea. Some reports (World Health Organization, unpublished data and personally accessed) suggest that malaria became endemic in both North and South Korea in 1998.
The main goal of this study was the molecular epidemiologic analysis of P. vivax in Korea (the origin of re-emerging malaria). The P. vivax merozoite contains a surface protein (Pv200) and has potent immunogenic activity in a natural infection. This molecule shows antigenic polymorphism at the genetic level. Two complete gene sequences of MSP-1 were reported in P. vivax, those of the Belem and Salvador-1 strains. 7, 8 The Pv200 gene consists of 10 units with conserved, semi-conserved, and variable blocks. The conserved region show intraspecies homology with other Plasmodium species, whereas the variable region, especially between interspecies conserved blocks 5 and 6, is highly polymorphic among P. vivax strains. 9, 12, 13 In addition to the type 1 (Belem) and type 2 (Salvador-1) variable regions, there is a third type of variable region, the inter-allelic recombination type, that is seen in strains from Sri Lanka, Colombia, and Thailand. 9, 10 Since MSP-1 has been considered as a vaccine candidate against P. vivax malaria, it is important to analyze the extent of sequence variation. Nucleotide sequence results were obtained for Korean isolates in 1996 (n ϭ 12) and 1997 (n ϭ 12). Type I amino acid sequences (CTEKAKPPDS-APVTSGQLLRGSSEAATEVTTNAVTSED) were found only before poly-Q repeats, whereas type II sequences ( N K P T V A A A D I V A K G Q S L R G A S E T G T T G N T-VNAQTAVVQ) were found before poly-Q repeats or Sal-1 type specific sequences (PQHQVVNAVTQPGTTGHQA-QGGEAETQTNSVQAA). 12 In our study, we observed 4-10 glutamine repeats of type I (Belem strain) in Korean isolates. Glutamine-encoding codons are mostly CAA and rarely CAG. Some nucleotide variation is observed in the number of poly-Q repeats in different Korea isolates (CAG to CGG, CAA to CGA, CAA to CCA, or CAA to CAT). A poly-Q repeat frequency of 10 was found in 21 of 24 sequenced isolates. A type 2 amino acid sequence consisting of 38 amino acids (NKPTVAAADIVAKGQSLRGASETGTTGNT-VNAQTAVVQ), was also found before the poly-Q repeat region in all Korean isolates. This indicates that inter-allelic recombination in the MSP-1 gene has occurred in all Korean isolates.
The results of nucleotide sequencing indicate that the Korean isolates are very similar to 2 Thai isolates: TD525 (94.5%) and TD424 (94.2%). Other Thai strains show greater differences in their sequences compared with the Korean isolates. The Korean isolates are unique and different from the other worldwide isolates. Understanding antigenic variations between different Plasmodium strains should assist in both malaria vaccine development and eradication efforts of this disease in Korea.
